{
    "Case ID": "042475",
    "Crime_Name": [
        "Patent Infringement Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Infringement Dispute"
    ],
    "Legal_Issue": [
        "Is Pfizer's '546 Patent a valid selection patent given the reliability of its experimental data and claims?"
    ],
    "Governing_Law": [
        "Patent Law"
    ],
    "Procedural_Stage": [
        "Trial/Adjudication"
    ],
    "Evidence_Assessment": [
        "Experimental data was unreliable due to solubility issues, inconsistent methodologies, and lack of reproducibility"
    ],
    "Decision_Outcome": [
        "'546 Patent is invalid"
    ],
    "Burden_of_Proof": [
        "On Pfizer to demonstrate validity of selection patent"
    ],
    "Credibility_Factor": [
        "Low credibility of experimental data"
    ],
    "Legal_Rule": [
        "A selection patent is valid if it discloses a substantial advantage, all selected members possess this advantage, and it relates to a quality peculiar to the selected group"
    ],
    "Standard_of_Review": [
        "Validity of patent claims based on substantive patent law standards"
    ],
    "Procedural_Issue": [
        "Sufficiency of disclosure and inventiveness in patent application"
    ],
    "Grounds_for_Claim": [
        "Alleged unexpected therapeutic advantage of atorvastatin calcium over racemates"
    ],
    "Outcome_on_Merits": [
        "Application dismissed; patent found invalid"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Patent invalidated"
    ],
    "Review_Standard": [
        "Substantial advantage and inventiveness required for selection patents"
    ],
    "Procedural_Fairness_Assessment": [
        "Court conducted full analysis of data, claims, and inventiveness"
    ],
    "Key_Evidence_Considered": [
        "Experimental data on solubility, methodology consistency, reproducibility, comparative efficacy"
    ],
    "Legal_Framework": [
        "Selection patent doctrine under patent law"
    ],
    "Applicant_Challenge": [
        "Pfizer sought to extend monopoly via selection patent"
    ],
    "Court_Result": [
        "Dismissal of application"
    ],
    "Legal_Rule_Source": [
        "Established patent law principles on selection patents"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities / preponderance of evidence"
    ],
    "Defendant_Response": [
        "Challenged reliability of data and sufficiency of disclosure"
    ],
    "Evidence_Type": [
        "Scientific/Experimental Data",
        "Comparative Pharmacological Studies"
    ],
    "Remedy_Requested": [
        "Invalidation of '546 Patent"
    ],
    "Outcome": [
        "'546 Patent declared invalid"
    ],
    "Decision_Authority": [
        "Judicial Court"
    ],
    "Remedy_Sought": [
        "Prevention of unjustified patent term extension"
    ],
    "Resolution_Mechanism": [
        "Judicial determination"
    ],
    "Legal_Provision": [
        "Patent Act provisions on novelty, inventiveness, and sufficiency"
    ],
    "Authority": [
        "National Patent Law/Judiciary"
    ],
    "Claimant_Status": [
        "Pfizer as patent holder"
    ],
    "Legal_Provision_Cited": [
        "Relevant sections on selection patents and patentability criteria"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Lack of reliable data, insufficient disclosure, no inventive step"
    ],
    "Applicable_Process": [
        "Litigation"
    ],
    "Outcome_of_Review": [
        "Patent invalidated"
    ],
    "Pending_Relief_or_Application": [
        "Dismissed"
    ],
    "Jurisdiction": [
        "National/Regional Patent Court or Equivalent"
    ],
    "Governing_Rule": [
        "Selection patent validity requirements"
    ]
}